Lanean...
Immune checkpoint inhibitors in small cell lung cancer
Small cell lung cancer (SCLC) is a rapidly progressive cancer that often debilitates patients within months of detection and quickly becomes refractory to the limited options of therapy. While SCLC is not generally considered an immunogenic tumor, clinical experience suggests that patients with robu...
Gorde:
| Argitaratua izan da: | J Thorac Dis |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
AME Publishing Company
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5861263/ https://ncbi.nlm.nih.gov/pubmed/29593891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.12.51 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|